Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
New England Journal of MedicinePublished 23 November 1995
Steven H. Woolf
Citations243
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Levels of prostate-specific antigen, a serine protease, are elevated in most men with clinically important prostate cancer and measuring them is the best means for early detection of the disease.
Abstract
After lung cancer, prostate cancer is the leading cause of deaths from cancer among men in the United States. It will claim 40,000 lives in 1995.1 Studies in the early 1990s demonstrated that levels of prostate-specific antigen (PSA), a serine protease, are elevated in most men with clinically important prostate cancer and that measuring them is the best means for early detection of the disease.25 In 1993, the American Cancer Society recommended that clinicians measure PSA in all men 50 years of age and older as part of an annual prostate examination and that PSA screening should begin at . . .
Keywords
Medicine
New England Journal of MedicineMeasurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
2,390 Citations1991William J. Catàlona, Deborah S. Smith +6 more
The combination of measurement of the serum PSA concentration and rectal examination, with ultrasonography performed in patients with abnormal findings, provides a better method of detecting prostate cancer thanrectal examination alone.
CA A Cancer Journal for CliniciansCancer statistics, 1995
1,430 Citations1995Phyllis A. Wingo, T. Tong +1 more
The American Cancer Society's Department of Epidemiology and Statistics reports its 29th annual compilation of cancer incidence, survival and mortality data for the United States and around the world.
The Journal of UrologyComparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men
1,422 Citations1994William J. Catàlona, John P. Richie +11 more
The use of PSA in conjunction with digital rectal examination enhances early prostate cancer detection and should be considered if either the PSA level is greater than 4 micrograms/l or digital rectAL examination is suspicious for cancer, even in the absence of abnormal transrectal ultrasonography findings.
The Journal of UrologyProstate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1,261 Citations1991Joseph E. Oesterling
It is unlikely that PSA by itself will become an effective screening tool for the early diagnosis of prostate cancer, but if combined with digital rectal examination and/or transrectal ultrasound it may become a vital part of any early detection program.
New England Journal of MedicineResults of Conservative Management of Clinically Localized Prostate Cancer
955 Citations1994Gerald W. Chodak, Ronald A. Thisted +8 more
The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
PubMedA complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
939 Citations1991Ulf‐Håkan Stenman, Jari Leinonen +4 more
The proportion of the PSA-alpha 1-antichymotrypsin complex was higher in patients with prostatic cancer than in those with benign hyperplasia, and assay of the complex had a higher sensitivity for cancer than assay of total PSA immunoreactivity.
The Journal of UrologyProstate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen
774 Citations1990William H. Cooner, B.R. Mosley +6 more
The Journal of UrologyProstate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer
768 Citations1992Mitchell C. Benson, Ihn Seong Whang +5 more
A quotient of serum PSA and prostate volume, which is referred to as prostate specific antigen density (PSAD), may be useful in distinguishing BPH and prostate cancer.
The Journal of UrologyThe Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
746 Citations1993Wael Sakr, Gabriel P. Haas +3 more
Prostatic intraepithelial neoplasia and histological cancers are surprisingly common in young male patients of both races, and appears to present several decades earlier than clinically detected carcinoma.
UrologyPatient-re ported complications and follow-up treatment after radical prostatectomy
640 Citations1993Floyd J. Fowler, Michael J. Barry +4 more
Estimates of complication and follow-up treatment rates are generally higher, and almost certainly more representative for older men, than estimates previously published.
JAMAPathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
386 Citations1994Jonathan I. Epstein
CA A Cancer Journal for CliniciansDefining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers
305 Citations1993Curtis Mettlin, Graeme Jones +3 more
JAMALongitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
305 Citations1992H. B. Carter
Annals of Internal MedicineProstate Cancer Screening: What We Know and What We Need To Know
276 Citations1993Barnett S. Kramer, Martin L. Brown +3 more
A number of scientific and economic uncertainties exist about the wisdom of widespread implementation of the PSA assay for screening, and these uncertainties justify a definitive randomized trial to determine whether screening for prostate cancer would reduce mortality from the disease.
Archives of Family MedicineA structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team
215 Citations1993John H. Wasson
Until better scientific evidence is available, patients and their physicians cannot make informed choices based on knowledge of the benefits of radical prostatectomy, radiation, or watchful waiting.
The Journal of UrologyProstate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute
213 Citations1994John K. Gohagan, Philip C. Prorok +2 more
The prostate, lung, colorectal and ovarian cancer (randomized, controlled) screening trial of the National Cancer Institute, to include 74,000 men and women, has a design power of 90% to determine a 20% reduction of prostate cancer mortality from a baseline and 3 subsequent annual screens using prostate specific antigen and digital rectal examination.
Urologic Clinics of North AmericaEarly Detection of Prostate Cancer
207 Citations1989Peter T. Scardino
The strong correlation between the prevalence of large, proliferative cancers found at autopsy and the clinical incidence and mortality rate of prostate cancer in populations around the world strongly supports the concept of a multistep process in the pathogenesis of the disease.
The Journal of UrologyThe Prostate Cancer Intervention Versus Observation Trial: A Randomized Trial Comparing Radical Prostatectomy Versus Expectant Management for the Treatment of Clinically Localized Prostate Cancer
190 Citations1994Timothy J Wilt, Michael K. Brawer
The Prostate Cancer Intervention Versus Observation Trial (PIVOT) is a randomized controlled trial sponsored by the Department of Veterans Affairs and the National Cancer Institute to determine which of 2 strategies is superior for managing clinically localized prostate cancer of all histological grades.
The Journal of UrologyCarcinoma of the Prostate in Elderly Men: Incidence, Growth Characteristics and Clinical Significance
157 Citations1969Russell Scott, David L. Mutchnik +2 more
British Journal of UrologyTransrectal Ultrasound Examination of the Prostate: Complications and Acceptance by Patients
151 Citations1993Gunnar Aus, Carl Gustaf Hermansson +2 more
Antibiotic treatment with 2 tablets of norfloxacin failed to prevent infection and TRUS and core biopsy proved acceptable to most patients, and the only risk factor identified for post-biopsy infection was steroid medication.
JAMAThe role of increasing detection in the rising incidence of prostate cancer
142 Citations1995Arnold L. Potosky
Urologic Clinics of North AmericaEconomics of Screening for Carcinoma of the Prostate
142 Citations1990Scott A. Optenberg, Ian M. Thompson
The authors demonstrate the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive.
Journal of Cancer Research and Clinical OncologyEpidemiologic aspects of latent and clinically manifest carcinoma of the prostate
135 Citations1983G. Dhom
Comparative geographic-pathologic autopsy studies on frequency and growth type of latent prostate carcinomas show that in populations with a lower incidence, for example Japan and Singapore, latent carcinomatous foci are not considerably rarer than in regions with high incidence, however, obvious differences are seen when comparing the size of the foci and the growth types.
JAMAA decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team
135 Citations1993C. Fleming
Radical prostatectomy and radiation therapy may benefit selected groups of patients with localized prostate cancer, particularly younger patients with higher-grade tumors, and watchful waiting is a reasonable alternative to invasive treatment for many men with localized prostatic carcinoma.
Journal of Clinical PathologyLatent Carcinoma of the Prostate
118 Citations1949G. S. Andrews
The incidence of carcinoma of the prostate in 1947 in the United Kingdom, according to the Registrar-General, was 0.98% of all male deaths, whereas several writers have reported a much higher incidence.
The LancetCase-control study of screening for prostatic cancer by digital rectal examinations
118 Citations1991G D Friedman, R A Hiatt +2 more
Screening by routine digital rectal examination appears to have little if any effect in preventing metastatic prostatic cancer, and if there is a small benefit, it will be difficult to demonstrate by conventional epidemiological study.
JAMALong-term survival among men with conservatively treated localized prostate cancer
112 Citations1995Peter C. Albertsen
The Journal of UrologyEarly Complications of Contemporary Anatomical Radical Retropubic Prostatectomy
111 Citations1994Gerald L. Andriole, Deborah S. Smith +3 more
It is shown that contemporary anatomical retropubic radical prostatectomy may be performed with acceptably low early morbidity and mortality rates, and that appropriate selection of chronologically older patients is not associated with significantly greater rates of early complications.
JNCI Journal of the National Cancer InstitutePrevalence of Latent Prostate Carcinoma in Two U.S. Populations<xref ref-type="fn" rid="fn2">2</xref>
106 Citations1980Joseph M. Guileyardo, William D. Johnson +3 more
The results suggest that many latent carcinomas lack promotional stimuli to become invasive, and may account for the excess of invasive carcinomas in blacks.
The Journal of UrologyA Critique of the Decision Analysis for Clinically Localized Prostate Cancer
105 Citations1994J. Robert Beck, Michael W. Kattan +1 more
The decision to operate on all grades of prostate cancer is strongly supported, and this finding contradicts that of the original PORT analysis, which suggested that surgery would decrease quality-adjusted life expectancy for patients with well differentiated lesions.
The Journal of UrologyMorbidity with Contemporary Prostate Biopsy
91 Citations1993Paul M. Desmond, Joseph Y. Clark +3 more
To determine the incidence of complications associated with contemporary prostate biopsy, a review of 670 men undergoing transrectal prostate biopsies using 18 gauge biopsy needles was conducted and demonstrated the low morbidity associated with modern trans rectal biopsy.
UrologyRadical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer A fifteen-year follow-up
90 Citations1990Peder H. Graversen, Donald K. Corle +3 more
In this study, initial treatment with radical prostatectomy did not yield longer survival than initial placebo treatment alone, and a statistically significant association between a high Gleason histologic score and poor survival was established.
CA A Cancer Journal for CliniciansThe benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project
88 Citations1993Peter J. Littrup, Allen C. Goodman +1 more
Under the assumptions of these analyses, the combination of PSA and DRE appears to represent an ethical and economical detection choice for individual patients in consultation with their physicians.
The Journal of UrologyExpectant Management of Early Stage Prostatic Cancer: Swedish Experience
78 Citations1994Jan‐Erik Johansson
Following an initial increase, the rate of disease progression and death from prostate cancer decreased during the last years of followup and any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.
The Journal of UrologyCharacteristics of Prostate Cancer Detected in the American Cancer Society-National Prostate Cancer Detection Project
66 Citations1994Curtis Mettlin, G P Murphy +8 more
PSA level and PSA density were associated with the detection of organ confined cancer but several advanced tumors had PSA levels in the normal range, and Age referenced PSA, compared to conventional standards, demonstrated lower sensitivity to cancer with little improvement in specificity.
CancerCarcinoma of the prostate in patients 70 to 79 years old
51 Citations1966B Halpert, William R. Schmalhorst
On step cross sections of the entire prostate gland in 100 patients aged 70 to 79, carcinoma was identified in 41, and it appears that focal carcinoma may be a stage in the development of diffuse carcinoma of the prostate.
PubMedThe evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
46 Citations1992J. W. Mold, David R. Holtgräve +4 more
The evaluation and treatment of prostatic nodules found by digital rectal examination in asymptomatic men in the primary care setting does not lead to significant improvement in life expectancy and adversely affects quality of life.
European UrologySerum Prostate-Specific AntigenDiscriminates Weakly betweenMen with Benign ProstaticHyperplasia and Patients withOrgan-Confined Prostate Cancer
45 Citations1994Peter Sershon, Michael J. Barry +1 more
It is suggested that serum PSA has only a modest ability to distinguish men with BPH from patients with organ-confined prostate cancer, and some symptomatic BPH patients choosing a non-TURP therapy may harbor a clinically significant prostate cancer despite being evaluated with a serum PSC determination.
Annals of Internal MedicineUsing Prostate-specific Antigen To Diagnose Prostate Cancer: Sailing in Uncharted Waters
45 Citations1993Patrick C. Walsh
The status of screening for prostate cancer is reviewed and it is pointed out that screening based on prostate-specific antigen (PSA) measurements may not be accurate and that the widespread adoption of such screening could lead to increased treatment-related mortality, reduced quality of life for patients who are treated, and a severe economic burden on the medical system.
The Journal of UrologyMortality of Patients after Radical Prostatectomy: Analysis of Recent Medicare Claims
42 Citations1994David Mark
A 100% sample of Medicare claims records of patients undergoing radical prostatectomy in 1990 was analyzed, and there was no trend of increasing 30-day mortality with patient age, and a modestly increased 1-year mortality rate with increasing age.
The Journal of UrologyMorbidity and Mortality Following Radical Prostatectomy: A National Analysis of Civilian Health and Medical Program of the Uniformed Services Beneficiaries
35 Citations1995Scott A. Optenberg, Barbara E. Wójcik +1 more
Data demonstrated that mortality and morbidity from radical prostatectomy were low and that conclusions drawn on outcomes of treatment for carcinoma of the prostate should focus on the entire age range of patients who undergo this procedure in the United States.
PubMedProstate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
32 Citations1994Gunnar Aus
According to these studies, PC is a progressive disease with considerable mortality and morbidity when managed by non-curative intention and it is reasonable to offer younger patients with long life expectancy the chance of early detection and treatment with curative intention.
Archives of Family MedicineProstate cancer screening. What family physicians believe is best
31 Citations1995Rodney J. Hicks
Although the literature has been inconclusive on the benefit of prostate cancer screening, the majority of Oklahoma family physicians would choose to screen their patients and believe that patients' mortality and morbidity are decreased by early identification of prostatecancer.
JAMADisease-specific survival following routine prostate cancer screening by digital rectal examination
22 Citations1993G. S. Gerber
The Journal of UrologyIn Reply: Re The Value of Serial Prostate Specific Antigen Determinations 5 Years After Radiotherapy
9 Citations1995T A Stamey, Michelle K. Ferrari +1 more